Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-21

Jing Mei Su, Yu Quan Wei, Ling Tian, Xia Zhao, Li Yang, Qiu Ming He, Yu Wang, You Lu, Yang Wu, Fen Liu, Ji Yan Liu, Jin Liang Yang, Yanyan Lou, Bing Hu, Ting Niu, Yan Jun Wen, Fei Xiao, Hong Xin Deng, Jiong Li, Bing Kan

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Matrix metalloproteinase (MMP) family, in particular MMP-2, may play a key role in angiogenesis and tumor growth. It is conceivable that the breaking of immune tolerance of MMP-2 should be a useful approach to cancer therapy by active immunity. To test this concept, we constructed a plasmid DNA encoding chicken homologous MMP-2 (c-MMP-2) and control vectors. We found that the vaccine based on chicken homologous MMP-2 as a model antigen could induce both protective and therapeutic antitumor immunity. Autoantibodies against MMP-2 in sera of mice immunized with c-MMP-2 could be found by Western blotting analysis and ELISA assay. There was the deposition of autoantibodies within the tumor. IGG1 and IgG2b were substantially increased in response to c-MMP-2 immunization. The elevation of MMP-2 in the sera of tumor-bearing mice was abrogated with the vaccination of c-MMP-2. Transmigration of human endothelial cells and tumor cells through gelatin-coated filters was inhibited with immunoglobulins isolated from mice immunized with c-MMP-2. The gelatinase activity of MMP-2, including both latent MMP-2 (Mr 72,000) and active MMP-2 (Mr 66,000) derived from tumor tissues, was apparently inhibited by the vaccination with c-MMP-2. The antitumor activity and the inhibition of angiogenesis were acquired by the adoptive transfer of the purified immunoglobulins. The antitumor activity and production of autoantibodies against MMP-2 could be abrogated by the depletion of CD4+ T lymphocytes. Angiogenesis was apparently inhibited within tumor, and chick CAMs angiogenesis was also inhibited. Thus, our findings may provide a vaccine strategy for cancer therapy through the induction of an autoimmune response against MMP-2 in a cross-reaction by the immunization with the single xenogeneic homologous MMP-2 gene and may be of importance in the additional exploration of the application of other xenogeneic homologous genes identified in human and other animal genome projects in cancer therapy.

Original languageEnglish (US)
Pages (from-to)600-607
Number of pages8
JournalCancer Research
Volume63
Issue number3
StatePublished - Feb 1 2003
Externally publishedYes

Fingerprint

Cancer Vaccines
Matrix Metalloproteinase 2
Matrix Metalloproteinases
Chickens
Neoplasms
Therapeutics
Autoantibodies
Immunoglobulins
Immunization
Vaccination
Active Immunity
Gelatinases
Immune Tolerance
Adoptive Transfer
Cross Reactions
Gelatin
Serum
Autoimmunity
Genes
Immunity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Su, J. M., Wei, Y. Q., Tian, L., Zhao, X., Yang, L., He, Q. M., ... Kan, B. (2003). Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-21 Cancer Research, 63(3), 600-607.

Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-21 . / Su, Jing Mei; Wei, Yu Quan; Tian, Ling; Zhao, Xia; Yang, Li; He, Qiu Ming; Wang, Yu; Lu, You; Wu, Yang; Liu, Fen; Liu, Ji Yan; Yang, Jin Liang; Lou, Yanyan; Hu, Bing; Niu, Ting; Wen, Yan Jun; Xiao, Fei; Deng, Hong Xin; Li, Jiong; Kan, Bing.

In: Cancer Research, Vol. 63, No. 3, 01.02.2003, p. 600-607.

Research output: Contribution to journalArticle

Su, JM, Wei, YQ, Tian, L, Zhao, X, Yang, L, He, QM, Wang, Y, Lu, Y, Wu, Y, Liu, F, Liu, JY, Yang, JL, Lou, Y, Hu, B, Niu, T, Wen, YJ, Xiao, F, Deng, HX, Li, J & Kan, B 2003, 'Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-21 ', Cancer Research, vol. 63, no. 3, pp. 600-607.
Su, Jing Mei ; Wei, Yu Quan ; Tian, Ling ; Zhao, Xia ; Yang, Li ; He, Qiu Ming ; Wang, Yu ; Lu, You ; Wu, Yang ; Liu, Fen ; Liu, Ji Yan ; Yang, Jin Liang ; Lou, Yanyan ; Hu, Bing ; Niu, Ting ; Wen, Yan Jun ; Xiao, Fei ; Deng, Hong Xin ; Li, Jiong ; Kan, Bing. / Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-21 In: Cancer Research. 2003 ; Vol. 63, No. 3. pp. 600-607.
@article{5a695474d3414a3cb0268d57ab7005c2,
title = "Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-21",
abstract = "Matrix metalloproteinase (MMP) family, in particular MMP-2, may play a key role in angiogenesis and tumor growth. It is conceivable that the breaking of immune tolerance of MMP-2 should be a useful approach to cancer therapy by active immunity. To test this concept, we constructed a plasmid DNA encoding chicken homologous MMP-2 (c-MMP-2) and control vectors. We found that the vaccine based on chicken homologous MMP-2 as a model antigen could induce both protective and therapeutic antitumor immunity. Autoantibodies against MMP-2 in sera of mice immunized with c-MMP-2 could be found by Western blotting analysis and ELISA assay. There was the deposition of autoantibodies within the tumor. IGG1 and IgG2b were substantially increased in response to c-MMP-2 immunization. The elevation of MMP-2 in the sera of tumor-bearing mice was abrogated with the vaccination of c-MMP-2. Transmigration of human endothelial cells and tumor cells through gelatin-coated filters was inhibited with immunoglobulins isolated from mice immunized with c-MMP-2. The gelatinase activity of MMP-2, including both latent MMP-2 (Mr 72,000) and active MMP-2 (Mr 66,000) derived from tumor tissues, was apparently inhibited by the vaccination with c-MMP-2. The antitumor activity and the inhibition of angiogenesis were acquired by the adoptive transfer of the purified immunoglobulins. The antitumor activity and production of autoantibodies against MMP-2 could be abrogated by the depletion of CD4+ T lymphocytes. Angiogenesis was apparently inhibited within tumor, and chick CAMs angiogenesis was also inhibited. Thus, our findings may provide a vaccine strategy for cancer therapy through the induction of an autoimmune response against MMP-2 in a cross-reaction by the immunization with the single xenogeneic homologous MMP-2 gene and may be of importance in the additional exploration of the application of other xenogeneic homologous genes identified in human and other animal genome projects in cancer therapy.",
author = "Su, {Jing Mei} and Wei, {Yu Quan} and Ling Tian and Xia Zhao and Li Yang and He, {Qiu Ming} and Yu Wang and You Lu and Yang Wu and Fen Liu and Liu, {Ji Yan} and Yang, {Jin Liang} and Yanyan Lou and Bing Hu and Ting Niu and Wen, {Yan Jun} and Fei Xiao and Deng, {Hong Xin} and Jiong Li and Bing Kan",
year = "2003",
month = "2",
day = "1",
language = "English (US)",
volume = "63",
pages = "600--607",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-21

AU - Su, Jing Mei

AU - Wei, Yu Quan

AU - Tian, Ling

AU - Zhao, Xia

AU - Yang, Li

AU - He, Qiu Ming

AU - Wang, Yu

AU - Lu, You

AU - Wu, Yang

AU - Liu, Fen

AU - Liu, Ji Yan

AU - Yang, Jin Liang

AU - Lou, Yanyan

AU - Hu, Bing

AU - Niu, Ting

AU - Wen, Yan Jun

AU - Xiao, Fei

AU - Deng, Hong Xin

AU - Li, Jiong

AU - Kan, Bing

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Matrix metalloproteinase (MMP) family, in particular MMP-2, may play a key role in angiogenesis and tumor growth. It is conceivable that the breaking of immune tolerance of MMP-2 should be a useful approach to cancer therapy by active immunity. To test this concept, we constructed a plasmid DNA encoding chicken homologous MMP-2 (c-MMP-2) and control vectors. We found that the vaccine based on chicken homologous MMP-2 as a model antigen could induce both protective and therapeutic antitumor immunity. Autoantibodies against MMP-2 in sera of mice immunized with c-MMP-2 could be found by Western blotting analysis and ELISA assay. There was the deposition of autoantibodies within the tumor. IGG1 and IgG2b were substantially increased in response to c-MMP-2 immunization. The elevation of MMP-2 in the sera of tumor-bearing mice was abrogated with the vaccination of c-MMP-2. Transmigration of human endothelial cells and tumor cells through gelatin-coated filters was inhibited with immunoglobulins isolated from mice immunized with c-MMP-2. The gelatinase activity of MMP-2, including both latent MMP-2 (Mr 72,000) and active MMP-2 (Mr 66,000) derived from tumor tissues, was apparently inhibited by the vaccination with c-MMP-2. The antitumor activity and the inhibition of angiogenesis were acquired by the adoptive transfer of the purified immunoglobulins. The antitumor activity and production of autoantibodies against MMP-2 could be abrogated by the depletion of CD4+ T lymphocytes. Angiogenesis was apparently inhibited within tumor, and chick CAMs angiogenesis was also inhibited. Thus, our findings may provide a vaccine strategy for cancer therapy through the induction of an autoimmune response against MMP-2 in a cross-reaction by the immunization with the single xenogeneic homologous MMP-2 gene and may be of importance in the additional exploration of the application of other xenogeneic homologous genes identified in human and other animal genome projects in cancer therapy.

AB - Matrix metalloproteinase (MMP) family, in particular MMP-2, may play a key role in angiogenesis and tumor growth. It is conceivable that the breaking of immune tolerance of MMP-2 should be a useful approach to cancer therapy by active immunity. To test this concept, we constructed a plasmid DNA encoding chicken homologous MMP-2 (c-MMP-2) and control vectors. We found that the vaccine based on chicken homologous MMP-2 as a model antigen could induce both protective and therapeutic antitumor immunity. Autoantibodies against MMP-2 in sera of mice immunized with c-MMP-2 could be found by Western blotting analysis and ELISA assay. There was the deposition of autoantibodies within the tumor. IGG1 and IgG2b were substantially increased in response to c-MMP-2 immunization. The elevation of MMP-2 in the sera of tumor-bearing mice was abrogated with the vaccination of c-MMP-2. Transmigration of human endothelial cells and tumor cells through gelatin-coated filters was inhibited with immunoglobulins isolated from mice immunized with c-MMP-2. The gelatinase activity of MMP-2, including both latent MMP-2 (Mr 72,000) and active MMP-2 (Mr 66,000) derived from tumor tissues, was apparently inhibited by the vaccination with c-MMP-2. The antitumor activity and the inhibition of angiogenesis were acquired by the adoptive transfer of the purified immunoglobulins. The antitumor activity and production of autoantibodies against MMP-2 could be abrogated by the depletion of CD4+ T lymphocytes. Angiogenesis was apparently inhibited within tumor, and chick CAMs angiogenesis was also inhibited. Thus, our findings may provide a vaccine strategy for cancer therapy through the induction of an autoimmune response against MMP-2 in a cross-reaction by the immunization with the single xenogeneic homologous MMP-2 gene and may be of importance in the additional exploration of the application of other xenogeneic homologous genes identified in human and other animal genome projects in cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=0037308585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037308585&partnerID=8YFLogxK

M3 - Article

C2 - 12566302

AN - SCOPUS:0037308585

VL - 63

SP - 600

EP - 607

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 3

ER -